Transcendent Capital Group »

Myriad Genetics shares owned by Transcendent Capital Group

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Transcendent Capital Group from 13F filings

Historical chart of Transcendent Capital Group investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Transcendent Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Transcendent Capital Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $12k 428 27.39

More positions owned by Transcendent Capital Group

Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Blackrock Ultra Blackrock Ultra (ICSH)
Ishares Tr S&p 500 Grwt Etf S&p 500 Grwt Etf (IVW)
Ishares Tr Core S&p Mcp Etf Core S&p Mcp Etf (IJH)
First Trust Etf Iv First Trust Enhanced Short First Tr Enh New (FTSM)
Spdr Portfolio S&p 500 Etf Portfolio S&p500 (SPLG)
Ishares Tr Core S&p500 Etf Core S&p500 Etf (IVV)
Vanguard Large-cap Etf Large Cap Etf (VV)
Capital Group Core Equity Etf Shs Creation Unit Shs Creation Uni (CGUS)
Jpmorgan Ultra-short Income Etf Ultra Shrt Inc (JPST)
Ishares Tr Core S&p Scp Etf Core S&p Scp Etf (IJR)
Ishares Tr S&p 500 Val Etf S&p 500 Val Etf (IVE)
Invesco Nasdaq 100 Etf Nasdaq 100 Etf (QQQM)
Ishares Tr S&p Mc 400gr Etf S&p Mc 400gr Etf (IJK)

View all positions for Transcendent Capital Group

Top funds holding Myriad Genetics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Earnest Partners
Bank of America Corporation
Disciplined Growth Investors
Artisan Partners Limited Partnership
Dimensional Fund Advisors
Sei Investments
Geode Capital Management
Nuveen Asset Management
Morgan Stanley
Glenview Captal Management
D. E. Shaw & Co

View all funds holding Myriad Genetics